<DOC>
	<DOCNO>NCT01198392</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety s-1 plus cisplatin versus 5-FU plus cisplatin first-line therapy treatment patient advance gastric cancer .</brief_summary>
	<brief_title>Trial S-1 Plus Cisplatin Gastric Cancer</brief_title>
	<detailed_description>This randomize , control , open-label , multicenter study . Patients randomize one two treatment arm : S-1 plus cisplatin 5-FU plus cisplatin .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologically confirm adenocarcinoma stomach inoperable locally advanced recurrent and/or metastatic disease . Male female . Age 18 75 . Previous chemotherapy advanced/metastatic disease ( prior adjuvant/neoadjuvant therapy allow least 6 month elapse completion adjuvant/neoadjuvant therapy enrolment study ) . Measurable disease , accord Response Evaluation Criteria Solid Tumours ( RECIST ) ECOG Performance status 0 , 1 2 Haematological , Biochemical Organ Function : Neutrophil count &gt; 2.0 × 10 9/L , platelet count &gt; 100 ×10 9/L . Serum bilirubin &lt; 1.5 × upper limit normal ( ULN ) ; , AST ALT &lt; 2.5 × ULN ( &lt; 5 × ULN patient liver metastasis ) ; , alkaline phosphatase &lt; 2.5 × ULN ( &gt; 5 × ULN patient liver metastasis , Creatinine clearance &gt; 60 mL/min . Signed informed consent . prior adjuvant/neoadjuvant therapy two regiment . Received investigational drug treatment within 30 day start study treatment . Patients active gastrointestinal bleeding . Neurological toxicity ≥ grade 2 NCICTCAE . Other malignancy within last 5 year , except carcinoma situ cervix , basal cell carcinoma . History clinical evidence brain metastasis . Serious uncontrolled systemic intercurrent illness , e.g . infection poorly control diabetes . Pregnancy woman . Subjects reproductive potential willing use effective method contraception . Patients know active infection HIV . Known hypersensitivity study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>gastric cancer</keyword>
</DOC>